| Date | Title | Description |
| 03.04.2023 | Digital health news, funding round up in the prior week; April 3, 2023 | SimpleTherapy bought PhysMetrics; Wellvana Health raised $84M; Parsley Health expanded to NY and CA
Top Health News
Mantra Health, a provider of virtual mental health services for college students, partnered with Togetherall, an online comm... |
| 16.12.2021 | Bigfoot Biomedical® Adds Depth With Experienced, Senior New Hires | With its Bigfoot Unity™ Diabetes Management Program fully commercial, Bigfoot looks to broaden access to diabetes centers, endocrinology practices and health systems in 2022, as well as expand its development pipeline
MILPITAS, Calif.–(BUSI... |
| 01.12.2021 | Bigfoot Clinic Hub™ Puts Critical Data at Fingertips of Health Care Professionals to Enable Proactive Care of their Patient Populations with Type 1 and Type 2 Diabetes | Cloud-based platform developed by Bigfoot Biomedical® automatically captures and presents insulin therapy data from the Bigfoot Unity System so clinics can proactively support patients at a distance
For health care professionals Clinic Hub ... |
| 24.06.2021 | Bigfoot Unity™ Program Now Available in US, Revolutionizes How Clinicians Support Patients to Successfully Manage their Diabetes | The program features first-of-its-kind technologies and a cloud-based platform that seamlessly connects clinics and health care providers to their Bigfoot Unity patients to enable continuous, proactive care – with or without an office visit... |
| 24.06.2021 | Bigfoot Unity™ Program Now Available in US, Revolutionizes How Clinicians Support Patients to Successfully Manage their Diabetes | Where does your enterprise stand on the AI adoption curve? Take our AI survey to find out.
The program features first-of-its-kind technologies and a cloud-based platform that seamlessly connects clinics and health care providers to their Bi... |
| 10.05.2021 | Bigfoot Biomedical® Receives FDA Clearance for Bigfoot Unity™ Diabetes Management System, Featuring First-of-its-Kind Smart Pen Caps for Insulin Pens used to Treat Type 1 and Type 2 Diabetes | Integrated with Abbott’s FreeStyle® Libre 2 system, the Bigfoot Unity System is the first and only to translate continuously monitored glucose data into on-demand insulin dose recommendations displayed right on the pen-cap screen for ease o... |
| 22.03.2021 | Bigfoot Biomedical Secures up to $57 Million in Combined Debt and Equity Financing From Madryn Asset Management | Bigfoot Biomedical, a company dedicated to better health outcomes for people with insulin-requiring diabetes, announced that it has secured new financing of up to $57 million from Madryn Asset Management LP, an alternative asset management ... |
| 19.03.2021 | Bigfoot Biomedical Secures Up To $57M in Debt and Equity Financing | Bigfoot Biomedical, a Milpitas, CA-based company dedicated to health outcomes for people with insulin-requiring diabetes, secured new debt and equity financing of up to $57m from Madryn Asset Management.
The company intends to use the proce... |
| 19.03.2021 | Bigfoot Biomedical Secures up to $57M Debt and Equity |
MILPITAS, CA, Bigfoot Biomedical has secured new financing of up to $57 million from Madryn Asset Management.
>> Click here for more funding data on Bigfoot Biomedical
>> To export Bigfoot Biomedical funding data to PDF and ... |
| 17.03.2021 | Bigfoot Biomedical® Secures up to $57 Million in Combined Debt and Equity Financing from Madryn Asset Management | MILPITAS, Calif.–(BUSINESS WIRE)–March 17, 2021–
Bigfoot Biomedical, a company dedicated to better health outcomes for people with insulin-requiring diabetes, announced today that it has secured new financing of up to $57 million from Madry... |
| 09.12.2020 | Bigfoot Biomedical® Builds Out Experienced Commercial Team, Announces New Hires | Company focused on broadening access to innovative solutions for people with type 1 and type 2 diabetes and designing high-touch customer care experiences
MILPITAS, Calif.–(BUSINESS WIRE)–December 9, 2020–
As it readies for FDA clearance of... |
| 12.06.2020 | Bigfoot Biomedical® Appoints Jim Malone MD Chief Medical Officer | Recognized endocrinologist and clinical researcher joins biotech start-up as company readies for submission of its innovative approach to diabetes management.
MILPITAS, Calif.–(BUSINESS WIRE)–June 12, 2020–
Bigfoot Biomedical, Inc. announce... |
| 05.06.2020 | Bigfoot Biomedical Closes $55M Series C Round |
MILPITAS, CA, Bigfoot Biomedical has raised a total of $55 million to close its Series C equity financing.
>> Click here for more funding data on Bigfoot Biomedical
>> To export Bigfoot Biomedical funding data to PDF and Exc... |
| 03.06.2020 | Diabetes Solutions Company Bigfoot Biomedical Raises $55 Million | Bigfoot Biomedical has announced that it raised a total of $55 million to close its Series C equity financing
Bigfoot Biomedical has announced that it raised a total of $55 million to close its Series C equity financing. This round of fundi... |
| 02.06.2020 | Bigfoot Biomedical® Closes Series C Financing with $55 Million as Company Readies for FDA Submission of Bigfoot Unity | Funding to Support its Breakthrough Therapy and Telemedicine Solutions for People Living with Insulin-Requiring Type 1 and Type 2 Diabetes
MILPITAS, Calif.–(BUSINESS WIRE)–June 2, 2020–
Bigfoot Biomedical, Inc. announced today that the comp... |
| 02.06.2020 | Bigfoot Biomedical Closes $55M Series C Financing | Bigfoot Biomedical, Inc., a Milpitas, Calif.-based developer of therapy and telemedicine Solutions for people living with Insulin-Requiring Type 1 and Type 2 Diabetes, raised a total of $55m to close its Series C equity financing.
The round... |
| 16.01.2020 | Bigfoot Biomedical announces $45M Series C tranche, expands partnership with Abbott | |
| 15.01.2020 | Bigfoot Biomedical lands $45M as it readies first diabetes product | That product, dubbed Bigfoot Unity, is a connected insulin pen that integrates Abbott’s FreeStyle Libre glucose sensing technology. The goal is to help people who inject insulin gauge when and how much to inject based on a doctor’s recommen... |
| 22.10.2018 | How big data is being used to advance precision health | At SplashX Precision Health, execs from UCSF, Helix, Stanford, HP, Bigfoot Biomedical, Virta Health
At SplashX Invent Health - Precision Health, tech pioneers and health incumbents talked about how they’re using big data to move toward more... |
| 02.10.2018 | At SplashX Precision Health: should patients self-diagnose? | Two different views over whether or not consumers should be diagnosing themselves
During Vator's salon, SplashX Invent Health - Precision Health, co-hosted and co-produced by our awesome partner, HP, there was a discussion about how data is... |
| 29.03.2018 | Term Sheet — Wednesday, March 29 | GOING PUBLIC
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
DocuSign announced Wednesday that it has filed its Form S-1 with the Securities and Exchange Commission. It still hasn’t re... |
| 29.03.2018 | Bigfoot brings in $55M Series B to propel integrated diabetes platform | While insulin keeps many people with type 1 (and sometimes type 2) diabetes alive, it’s a tricky drug to manage. Too much can crater glucose levels and too little can spike them. Either mistake can be debilitating or deadly. The Milpitas, C... |
| 29.03.2018 | Bigfoot Biomedical Closes $55M Series B Financing | Bigfoot Biomedical, Inc., a Milpitas, Calif.-based diabetes solutions company, completed a $55m Series B equity financing.
Backers included Abbott and other new and existing investors.
This round – which follows a $36m Series A financing in... |
| 29.03.2018 | Bigfoot Biomedical Closes $55M Series B |
MILPITAS, CA, Diabetes solutions company announced that the company has completed a $55 million Series B equity financing.
>> Click here for more funding data on Bigfoot Biomedical
>> To export Bigfoot Biomedical funding dat... |
| 21.12.2017 | Bigfoot Biomedical closes $37M Series B as it prepares for clinical trials of insulin delivery tech | Bigfoot is developing Bigfoot Loop to optimize insulin delivery specific to the user’s needs. A second product, Bigfoot Inject, is a connected insulin pen-based system for people on injection therapy. The insulin pen product is tied to the ... |
| 19.12.2017 | Term Sheet — Tuesday, December 19 | WHY NOT MORE?
Good morning, Term Sheet readers.
Paid Content How can you protect what you can't see? From ExtraHop
Lemonade, a New York-based peer-to-peer insurance company powered by artificial intelligence, raised $120 million in Series C... |
| 19.12.2017 | Bigfoot Biomedical Raises Initial $37M Series B Financing | Bigfoot Biomedical, a Milpitas, Calif.-based medical device company, raised $37m in the initial tranche of a Series B equity financing.
The round was co-led by funds managed by new investor Janus Henderson Investors, with participation from... |
| 18.12.2017 | Bigfoot Biomedical's automated insulin delivery systems attract $37M in Series B funding | Milpitas, California-based diabetes management device maker Bigfoot Biomedical has raised $37 million in Series B funding in a round co-led by funds from Janus Henderson Investors and Quadrant Capital Advisors. Additional participants inclu... |
| 05.06.2017 | Video:Jeffrey Brewer on diabetes management via smart device | Reena Jadhav interviews Founder & CEO of Bigfoot Biomedical
Reena Jadhav interviews Jeffrey Brewer, Founder CEO of Bigfoot Biomedical who has developed an automated insulin delivery system connected to a smartphone and the cloud, making... |
| 19.10.2016 | Bigfoot Biomedical gets $35.5M for connected, automated insulin delivery system | Milpitas, California-based diabetes management company Bigfoot Biomedical has raised $35.5 million in Series A funding in a round with participation from Cormorant Asset Management, Senvest Capital and Visionnaire Ventures. The funding will... |
| 12.09.2016 | Details scant, but Verily-Sanofi’s $500M diabetes JV aims to change behavior | However, what exactly the platform is and what products will emerge from this new company based in Cambridge, Massachusetts, is far from crystal clear.
Apparently even to the executives involved.
“The reality is that we don’t have a product... |
| 14.05.2015 | Diabetes: Bigfoot Biomedical raises $3m | Bigfoot Biomedical, which is developing a "bionic pancreas," said it raised $3 million from 8 unnamed investors.
Although it’s in stealth mode, Bigfoot executives have said they’d like to complete product development by 2016. The ... |
| 13.05.2015 | Bigfoot Biomedical’s artificial pancreas is emerging from hack mode with a $15M Series A in the works | Bigfoot is, after all, led by a trio of top-notch talent – who also happen to be fathers whose children are Type 1 diabetics. There’s Bryan Mazlish, the founder, a former Wall Street trader that built a smartphone app whose algorithms decip... |
| - | Details scant, but Verily-Sanofi’s $500M diabetes JV aims to change behavior | $248 million in cash from Sanofi, and the same amount in a capital contribution by Verily (not in cash) have breathed life to a new company — Onduo — where the two equal partners will wage battle with a formidable enemy: diabetes.
That part... |
| - | Bigfoot Biomedical’s artificial pancreas is emerging from hack mode with a $15M Series A in the works | Bigfoot Biomedical, known best for its grassroots approach to building an artificial pancreas for Type 1 diabetes, is emerging from hacker mode and raising some capital. The startup just brought in a $3.5 million bridge convertible note, an... |
| - | Bigfoot Biomedical lands $45M as it readies first diabetes product | Bigfoot Biomedical Inc. has picked up some ammunition as it moves closer to commercializing its insulin-management solution, an up-and-coming competitor in a space dominated so far by giants like Dexcom and Medtronic.
Bigfoot, based in Milp... |
| - | Bigfoot brings in $55M Series B to propel integrated diabetes platform | This week, Bigfoot Biomedical announced a $55 million Series B to advance their push to integrate glucose monitoring, insulin delivery and smart software. The financing will support a pivotal trial and other efforts to gain premarket approv... |
| - | Bigfoot Biomedical closes $37M Series B as it prepares for clinical trials of insulin delivery tech | Five months after signing a deal with Abbott to integrate the medical device giant’s FreeStyle Libre glucose sensing technology to optimize insulin delivery, Bigfoot Biomedical has closed a Series B round to support product development and ... |
